- Home
- BBIO vs AYI Comparison
BBIO vs AYI Comparison
Compare BBIO & AYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- AYI
- Stock Information
- Founded
- BBIO 2015
- AYI 2001
- Country
- BBIO United States
- AYI United States
- Employees
- BBIO N/A
- AYI N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- AYI Building Products
- Sector
- BBIO Health Care
- AYI Consumer Discretionary
- Exchange
- BBIO Nasdaq
- AYI Nasdaq
- Market Cap
- BBIO 9.4B
- AYI 10.2B
- IPO Year
- BBIO 2019
- AYI N/A
- Fundamental
- Price
- BBIO $53.33
- AYI $344.51
- Analyst Decision
- BBIO Strong Buy
- AYI Buy
- Analyst Count
- BBIO 16
- AYI 5
- Target Price
- BBIO $64.44
- AYI $352.60
- AVG Volume (30 Days)
- BBIO 2.1M
- AYI 214.0K
- Earning Date
- BBIO 11-11-2025
- AYI 10-01-2025
- Dividend Yield
- BBIO N/A
- AYI 0.20%
- EPS Growth
- BBIO N/A
- AYI 3.17
- EPS
- BBIO N/A
- AYI 12.69
- Revenue
- BBIO $235,812,000.00
- AYI $4,168,800,000.00
- Revenue This Year
- BBIO $115.97
- AYI $14.66
- Revenue Next Year
- BBIO $65.50
- AYI $9.20
- P/E Ratio
- BBIO N/A
- AYI $27.16
- Revenue Growth
- BBIO 7.62
- AYI 9.16
- 52 Week Low
- BBIO $21.72
- AYI $216.81
- 52 Week High
- BBIO $54.60
- AYI $348.62
- Technical
- Relative Strength Index (RSI)
- BBIO 60.01
- AYI 64.07
- Support Level
- BBIO $49.94
- AYI $337.50
- Resistance Level
- BBIO $54.29
- AYI $348.62
- Average True Range (ATR)
- BBIO 2.06
- AYI 7.96
- MACD
- BBIO -0.18
- AYI 0.00
- Stochastic Oscillator
- BBIO 73.81
- AYI 83.37
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About AYI Acuity Brands Inc.
Acuity is a leading industrial technology company that offers lighting, lighting controls, and intelligent building solutions. Acuity, Inc. designs, manufactures, and brings to market products and services relating to these and other offerings. Acuity, Inc. has two reportable segments: Acuity Brands Lighting and Acuity Intelligent Spaces. ABL sells commercial, architectural, and specialty lighting, including components and control systems. AIS offers building management and audio/visual solutions to help make buildings intelligent.